Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Heart Failure

  Free Subscription


14.06.2021

2 Am Heart J
2 Am J Cardiol
1 Basic Res Cardiol
1 BMJ
2 Cardiovasc Res
2 Chest
2 Circ Res
7 Circulation
2 Clin Cardiol
7 Eur Heart J
9 Eur J Heart Fail
3 Heart
4 Int J Cardiol
2 J Am Coll Cardiol
7 J Card Fail
3 J Cardiol
1 PLoS Med
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. FUDIM M, Spates T, Sun JL, Kittipibul V, et al
    Early Diuretic Strategies and the Association With In-Hospital and Post-Discharge Outcomes in Acute Heart Failure.
    Am Heart J. 2021 May 27. pii: S0002-8703(21)00140.
    PubMed         Abstract available

  2. NUNEZ-GIL IJ, Olier I, Feltes G, Viana-Llamas MC, et al
    Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry.
    Am Heart J. 2021;237:104-115.
    PubMed         Abstract available


    Am J Cardiol

  3. ABUGROUN A, Elawad A, Okoh AK, Abdel-Rahman ME, et al
    Impact of Atrial Fibrillation on Hospitalization Outcomes of Heart Failure in Patients >/= 60 Years with Implantable Cardioverter Defibrillator.
    Am J Cardiol. 2021 Jun 2. pii: S0002-9149(21)00370.
    PubMed         Abstract available

  4. FARIDI KF, Bhalla N, Atreja N, Venditto J, et al
    New Heart Failure After Myocardial Infarction (From the National Cardiovascular Data Registries [NCDR] Linked With All-Payer Claims).
    Am J Cardiol. 2021 May 27. pii: S0002-9149(21)00373.
    PubMed         Abstract available


    Basic Res Cardiol

  5. REMES A, Wagner AH, Schmiedel N, Heckmann M, et al
    AAV-mediated expression of NFAT decoy oligonucleotides protects from cardiac hypertrophy and heart failure.
    Basic Res Cardiol. 2021;116:38.
    PubMed         Abstract available


    BMJ

  6. KIM D, Yang PS, You SC, Sung JH, et al
    Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study.
    BMJ. 2021;373:n991.
    PubMed         Abstract available


    Cardiovasc Res

  7. NAUMENKO N, Mutikainen M, Holappa L, Ruas JL, et al
    PGC-1alpha deficiency reveals sex-specific links between cardiac energy metabolism and EC-coupling during development of heart failure in mice.
    Cardiovasc Res. 2021 Jun 4. pii: 6292089. doi: 10.1093.
    PubMed         Abstract available

  8. SANSONETTI M, De Windt LJ
    Non-coding RNAs in cardiac inflammation: key drivers in the pathophysiology of heart failure.
    Cardiovasc Res. 2021 Jun 7. pii: 6294284. doi: 10.1093.
    PubMed         Abstract available


    Chest

  9. DE MAN FS, Naeije R
    Sex and the Right Ventricle in Heart Failure With Preserved Ejection Fraction.
    Chest. 2021;159:2156-2158.
    PubMed        

  10. SIA YT, Gebhard CE, Denault AY
    Reversal of Acute Right Ventricular Failure Early Post Left Ventricular Assist Device Placement by Intratracheal Milrinone Administration: Case Report.
    Chest. 2021;159:e57-e60.
    PubMed        


    Circ Res

  11. HUO JL, Jiao L, An Q, Chen X, et al
    Myofibroblast Deficiency of LSD1 Alleviates TAC-Induced Heart Failure.
    Circ Res. 2021 Jun 3. doi: 10.1161/CIRCRESAHA.120.318149.
    PubMed         Abstract available

  12. GLASENAPP A, Derlin K, Gutberlet M, Hess A, et al
    Molecular Imaging of Inflammation and Fibrosis in Pressure Overload Heart Failure.
    Circ Res. 2021 Jun 2. doi: 10.1161/CIRCRESAHA.120.318539.
    PubMed         Abstract available


    Circulation

  13. LEE H, Yano Y, Cho SMJ, Park JH, et al
    Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults.
    Circulation. 2020;141:1778-1786.
    PubMed         Abstract available

  14. MOAYEDI Y, Runeckles K, Posada JD
    Letter by Moayedi et al Regarding Article, "Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results".
    Circulation. 2021;143:e1015-e1016.
    PubMed        

  15. MEHMOOD M
    Letter by Mehmood Regarding Article, "Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results".
    Circulation. 2021;143:e1014.
    PubMed        

  16. JENSEN J, Omar M, Kistorp C, Tuxen C, et al
    Metabolic Effects of Empagliflozin in Heart Failure: A Randomized, Double-Blind, and Placebo-Controlled Trial (Empire HF Metabolic).
    Circulation. 2021;143:2208-2210.
    PubMed        

  17. BIRKS EJ, Rame JE, Cunningham C, Drakos SG, et al
    Response by Birks et al to Letters Regarding Article, "Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results".
    Circulation. 2021;143:e1017-e1018.
    PubMed        

  18. FELKER GM, Butler J, Januzzi JL Jr, Desai AS, et al
    Probabilistic Readjudication of Heart Failure Hospitalization Events in the PARAGON-HF Study.
    Circulation. 2021;143:2316-2318.
    PubMed        


  19. Correction to: Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction.
    Circulation. 2021;143:e1027.
    PubMed        


    Clin Cardiol

  20. VAN WOERDEN G, van Veldhuisen DJ, Gorter TM, van Empel VPM, et al
    Importance of epicardial adipose tissue localization using cardiac magnetic resonance imaging in patients with heart failure with mid-range and preserved ejection fraction.
    Clin Cardiol. 2021 Jun 4. doi: 10.1002/clc.23644.
    PubMed         Abstract available

  21. SEKMA A, Bel Haj Ali K, Jeddi C, Ben Brahim N, et al
    Value of nitroglycerin test in the diagnosis of heart failure in emergency department patients with undifferentiated dyspnea.
    Clin Cardiol. 2021 Jun 2. doi: 10.1002/clc.23615.
    PubMed         Abstract available


    Eur Heart J

  22. WITHAAR C, Meems LMG, de Boer RA
    Fighting HFpEF in women: taking aim at belly fat.
    Eur Heart J. 2021;42:1606-1608.
    PubMed        

  23. RAJAGOPALAN S, Brook RD, Al-Kindi S
    Air pollution and flooding in the lungs: modern insights into ancient problems.
    Eur Heart J. 2021;42:1592-1594.
    PubMed        

  24. PORCHER R, Desguerre I, Amthor H, Chabrol B, et al
    Association between prophylactic angiotensin-converting enzyme inhibitors and overall survival in Duchenne muscular dystrophy-analysis of registry data.
    Eur Heart J. 2021;42:1976-1984.
    PubMed         Abstract available

  25. MARSTON NA, Han L, Olivotto I, Day SM, et al
    Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy.
    Eur Heart J. 2021;42:1988-1996.
    PubMed         Abstract available

  26. ZANNAD F, Cotter G, Alonso Garcia A, George S, et al
    What can heart failure trialists learn from oncology trialists?
    Eur Heart J. 2021 Jun 2. pii: 6291019. doi: 10.1093.
    PubMed         Abstract available

  27. JANKOWSKA EA, Kirwan BA, Kosiborod M, Butler J, et al
    The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study.
    Eur Heart J. 2021 Jun 3. pii: 6291468. doi: 10.1093.
    PubMed         Abstract available

  28. NICHOLLS M
    Recognition for heart failure breakthrough.
    Eur Heart J. 2021 Jun 11. pii: 6296965. doi: 10.1093.
    PubMed        


    Eur J Heart Fail

  29. STOLFO D, Savarese G
    Association Between Heart Failure and Cancer: Is Gender the Answer?
    Eur J Heart Fail. 2021 Jun 11. doi: 10.1002/ejhf.2261.
    PubMed        

  30. BHATT AS, Vaduganathan M, Claggett BL, Liu J, et al
    Effect of Sacubitril/Valsartan versus Enalapril on Changes in Heart Failure Therapies Over Time: The PARADIGM-HF Trial.
    Eur J Heart Fail. 2021 Jun 7. doi: 10.1002/ejhf.2259.
    PubMed         Abstract available

  31. PACKER M, Januzzi JL Jr, Ferreira JP, Anker SD, et al
    Concentration-Dependent Clinical and Prognostic Importance of High-Sensitivity Cardiac Troponin T in Heart Failure and a Reduced Ejection Fraction and the Influence of Empagliflozin: the EMPEROR-Reduced Trial.
    Eur J Heart Fail. 2021 May 30. doi: 10.1002/ejhf.2256.
    PubMed         Abstract available

  32. BUTLER J, Yang M, Sawhney B, Chakladar S, et al
    Treatment Patterns and Clinical Outcomes Among Patients <65 Years with a Worsening Heart Failure Event.
    Eur J Heart Fail. 2021 May 30. doi: 10.1002/ejhf.2252.
    PubMed         Abstract available

  33. SORIMACHI H, Burkhoff D, Verbrugge FH, Omote K, et al
    Obesity, Venous Capacitance, and Venous Compliance in Heart Failure with Preserved Ejection Fraction.
    Eur J Heart Fail. 2021 May 30. doi: 10.1002/ejhf.2254.
    PubMed         Abstract available

  34. GRAHAM FJ, Masini G, Pellicori P, Cleland JGF, et al
    Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure.
    Eur J Heart Fail. 2021 May 28. doi: 10.1002/ejhf.2251.
    PubMed         Abstract available

  35. FADINI GP, Avogaro A
    A simple way to spotlight hidden heart failure in type 2 diabetes?
    Eur J Heart Fail. 2021 May 28. doi: 10.1002/ejhf.2258.
    PubMed        

  36. TKACZYSZYN M, Comin-Colet J, Voors AA, van Veldhuisen DJ, et al
    Iron deficiency contributes to the resistance to endogenous erythropoietin in anaemic heart failure patients.
    Eur J Heart Fail. 2021 May 29. doi: 10.1002/ejhf.2253.
    PubMed         Abstract available

  37. SOLOMON SD, de Boer RA, DeMets D, Hernandez AF, et al
    Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial.
    Eur J Heart Fail. 2021 May 29. doi: 10.1002/ejhf.2249.
    PubMed         Abstract available


    Heart

  38. MULDER BA, Rienstra M, Van Gelder IC, Blaauw Y, et al
    Update on management of atrial fibrillation in heart failure: a focus on ablation.
    Heart. 2021 Jun 4. pii: heartjnl-2020-318081. doi: 10.1136/heartjnl-2020-318081.
    PubMed         Abstract available

  39. DESAI RJ, Patorno E, Vaduganathan M, Mahesri M, et al
    Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical care.
    Heart. 2021 Jun 4. pii: heartjnl-2021-319405. doi: 10.1136/heartjnl-2021-319405.
    PubMed         Abstract available

  40. GRIFFIN J, Cheng R
    Real-world utilisation of angiotensin-neprilysin inhibitors in older adults with heart failure.
    Heart. 2021 Jun 4. pii: heartjnl-2021-319545. doi: 10.1136/heartjnl-2021-319545.
    PubMed        


    Int J Cardiol

  41. RAJDEV K, Lahan S, Wichman T
    Role of pulmonary arterial capacitance in predicting mortality in patients with pulmonary hypertension: A systematic review and meta-analysis.
    Int J Cardiol. 2021 Feb 20. pii: S0167-5273(21)00296.
    PubMed         Abstract available

  42. VALERIANOVA A, Malik J, Janeckova J, Kovarova L, et al
    Reduction of arteriovenous access blood flow leads to biventricular unloading in haemodialysis patients.
    Int J Cardiol. 2021;334:148-153.
    PubMed         Abstract available

  43. LIU L, Lima JAC, Post WS, Szklo M, et al
    Associations of time-varying obesity and metabolic syndrome with risk of incident heart failure and its subtypes: Findings from the Multi-Ethnic Study of Atherosclerosis.
    Int J Cardiol. 2021 Jun 2. pii: S0167-5273(21)00908.
    PubMed         Abstract available

  44. EMOTO T, Hayashi T, Tabata T, Yamashita T, et al
    Metagenomic analysis of gut microbiota reveals its role in trimethylamine metabolism in heart failure.
    Int J Cardiol. 2021 Jun 5. pii: S0167-5273(21)00962.
    PubMed         Abstract available


    J Am Coll Cardiol

  45. JEAN G, Van Mieghem NM, Gegenava T, van Gils L, et al
    Moderate Aortic Stenosis in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2021;77:2796-2803.
    PubMed         Abstract available

  46. CONDORELLI G, Ferrante G
    MicroRNA-132 Inhibition Prevents Myocardial Hypertrophy and Heart Failure in Pigs: Making Sense Out of Antisense.
    J Am Coll Cardiol. 2021;77:2936-2938.
    PubMed        


    J Card Fail

  47. ALBERT NM
    Heart Failure is Everywhere: Insuring Diversity in Care Across Gender, Age, Race and Ethnicities.
    J Card Fail. 2021;27:722-723.
    PubMed        

  48. GERMAN CA, Brubaker PH, Nelson MB, Fanning J, et al
    Relationships Between Objectively Measured Physical Activity, Exercise Capacity, and Quality of Life in Older Patients With Obese Heart Failure and Preserved Ejection Fraction.
    J Card Fail. 2021;27:635-641.
    PubMed         Abstract available

  49. BLUMER V, Correa A, Youmans QR
    The Early Career and Trainee Spotlight at the Journal of Cardiac Failure.
    J Card Fail. 2021;27:716-717.
    PubMed        

  50. FERRARO RA, Ogunmoroti O, Zhao D, Ndumele CE, et al
    Hepatocyte Growth Factor and Incident Heart Failure Subtypes: The Multi-Ethnic Study of Atherosclerosis (MESA).
    J Card Fail. 2021 May 26. pii: S1071-9164(21)00194.
    PubMed         Abstract available

  51. AMAR M, Lam SW, Faulkenberg K, Perez A, et al
    Captopril versus hydralazine-isosorbide dinitrate vasodilator protocols in acute decompensated heart failure patients transitioning from sodium nitroprusside.
    J Card Fail. 2021 May 26. pii: S1071-9164(21)00197.
    PubMed         Abstract available

  52. OBATA H, Izumi T, Yamashita M, Mitsuma W, et al
    Characteristics of Elderly Patients with Heart Failure and Impact on Activities of Daily Living. A Registry Report from Super-Aged Society: ADL in elderly heart failure patients.
    J Card Fail. 2021 May 27. pii: S1071-9164(21)00198.
    PubMed         Abstract available

  53. GELFMAN LP, Mather H, McKendrick K, Wong AY, et al
    Non-Concordance between Patient and Clinician Estimates of Prognosis in Advanced Heart Failure.
    J Card Fail. 2021;27:700-705.
    PubMed         Abstract available


    J Cardiol

  54. TOMII D, Horiuchi Y, Gonda Y, Yoshiura D, et al
    The role of the renal resistance index in patients with heart failure with reduced or preserved ejection fraction.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00130.
    PubMed         Abstract available

  55. NISHIKIMI T, Nakagawa Y
    Potential pitfalls when interpreting plasma BNP levels in heart failure practice.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00114.
    PubMed         Abstract available

  56. YANAGIHARA K, Kinugasa Y, Kunimi T, Kaneko S, et al
    Child ego state and self-care behavior change in heart failure patients.
    J Cardiol. 2021 Jun 2. pii: S0914-5087(21)00128.
    PubMed         Abstract available


    PLoS Med

  57. AHN HJ, Lee SR, Choi EK, Han KD, et al
    Association between exercise habits and stroke, heart failure, and mortality in Korean patients with incident atrial fibrillation: A nationwide population-based cohort study.
    PLoS Med. 2021;18:e1003659.
    PubMed         Abstract available


    PLoS One

  58. TAKAHASHI S, Tanno K, Yonekura Y, Ohsawa M, et al
    Low educational level increases functional disability risk subsequent to heart failure in Japan: On behalf of the Iwate KENCO study group.
    PLoS One. 2021;16:e0253017.
    PubMed         Abstract available

  59. MAHESRI M, Chin K, Kumar A, Barve A, et al
    External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure.
    PLoS One. 2021;16:e0252903.
    PubMed         Abstract available

  60. IBE T, Wada H, Sakakura K, Ugata Y, et al
    Cardiac index predicts long-term outcomes in patients with heart failure.
    PLoS One. 2021;16:e0252833.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: